Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibitionMarkus V. Heppt, Carola Berking, Michael Constantin Kirchberger et al.|European Journal of Cancer|2017Cited by 203
Prognostic factors and outcomes in metastatic uveal melanoma treated with PD-1 or combined PD-1 / CTLA-4 inhibitionMarkus V. Heppt, Carola Berking, Lucie Heinzerling et al.|Journal Der Deutschen Dermatologischen Gesellschaft|2017Cited by 0